Results 181 to 190 of about 12,518 (290)

Knowledge and Confidence in Psychotropic Prescribing, Utilisation of Guidelines and Resources in Managing Perinatal Mental Health in General Practice: An Australian Cross‐Sectional Survey

Australian Journal of Rural Health, Volume 34, Issue 1, February 2026.
ABSTRACT Objective Management of psychiatric disorders in the perinatal period is a common presentation in primary care. There is a need to understand how general practitioners (GPs) use guidelines and resources and incorporate the knowledge within clinical practice.
Jacqueline Frayne, Sarah Seddon, Tamara Lebedevs, Talila Milroy, Beverly Teh, Thinh Nguyen   +5 more
wiley   +1 more source

Capability, opportunity and motivation for shared decision‐making about valproate as an antiseizure medication treatment for epilepsy in women with pregnancy potential: A qualitative study of patient perspectives

British Journal of Health Psychology, Volume 31, Issue 1, February 2026.
Abstract Objectives Valproate is a highly effective antiseizure medication but carries significant teratogenic and neurodevelopmental risks to offspring if used during pregnancy. A shared decision‐making (SDM) approach is recommended to guide clinician/patient discussions on valproate suitability for women with pregnancy potential.
Sarah Louise Griffiths, Delyth James, Denitza Williams, Lynette James, Andrew Evans, William O. Pickrell, Christine McKnight, Sarah Brown, Rhiannon Phillips   +8 more
wiley   +1 more source

Faculty Opinions recommendation of Teratogen-induced oxidative stress targets glyceraldehyde-3-phosphate dehydrogenase in the organogenesis stage mouse embryo.

, 2010
Philip Burcham
openalex   +2 more sources

Metformin safety during pregnancy in women with gestational diabetes mellitus: A systematic review and meta‐analysis of maternal, neonatal and long‐term outcomes

Diabetic Medicine, Volume 43, Issue 2, February 2026.
Abstract Aims This systematic review and meta‐analysis assessed the safety and efficacy of metformin in managing gestational diabetes mellitus (GDM), focusing on maternal, neonatal and long‐term outcomes. While lifestyle changes are first‐line treatment, pharmacological therapy is often required.
Mathilde Louise Saxdorff Brinkmann, Nicoline Josefine Krasilnikoff, Mariam Ali Chaaban, Birgitte Moeller Luef, Christine Newman, Fidelma Dunne, Dorte Moeller Jensen, Christina Anne Vinter   +7 more
wiley   +1 more source

Risk and Benefit of Drug Use During Pregnancy

International Journal of Medical Sciences, 2005
Environmental teratogenic factors (e.g. alcohol) are preventable. We focus our analysis on human teratogenic drugs which are not used frequently during pregnancy. The previous human teratogenic studies had serious methodological problems, e.g.
doaj  

Uji Efek Teratogen Ekstrak Etanol Daun Sirsak (Annona muricata L) Terhadap Fetus Mencit Putih

, 2017
Ifora Ifora, Suhatri Suhatri, Suzie Yolandha   +2 more
openalex   +2 more sources

Teratogen update: antithyroid drugs—methimazole, carbimazole, and propylthiouracil [PDF]

, 2002
Orna Diav‐Citrin, Asher Ornoy
openalex   +1 more source

Associations of modifiable preconception, pregnancy and postpartum factors with health outcomes for women with type 2 diabetes and their children: A systematic review and meta‐analysis of observational studies

Diabetic Medicine, Volume 43, Issue 2, February 2026.
Abstract Aim Type 2 diabetes (T2D) in pregnancy is increasingly common and associated with suboptimal outcomes for these women and their children. We aimed to synthesize observational evidence on associations of modifiable preconception, pregnancy and postpartum risk factors with perinatal outcomes among women with pregestational T2D.
Danielle Schoenaker, Eleanor Dyer, Nicola Heslehurst, Grainne Kent, Sowmiya Gunabalasingam, Lily Hopkins, Artemis Kyrka, Rivka Lebrett, Angela C. Flynn, Sara L. White, Claire L. Meek, Rita Forde   +11 more
wiley   +1 more source

Antipsychotic drug use during pregnancy and neonatal outcomes: a systematic review and meta-analysis. [PDF]

Arch Womens Ment Health
Quinn D, Donnelly M, O'Neill C.
europepmc   +1 more source

2-1) SENSITIVE PHASES FOR TERATOGEN-INDUCED DEVELOPMENTAL DEFECTS IN THE BRAIN

, 1991
Y Kameyama
openalex   +2 more sources